Adline Chem Lab Ltd.
Snapshot View

10.43 ▼0%

23 September 2022, 04:01:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kamronlabs.com
Market Cap 6.10 Cr.
Enterprise Value(EV) 7.37 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 1.54 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 6.79 Trailing Twelve Months Ending 2022-06
Industry PE 30.55 Trailing Twelve Months Ending 2022-06
Book Value / Share 4.36 Trailing Twelve Months Ending 2022-06
Price to Book Value 2.39 Calculated using Price: 10.43
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.59 Cr. 5,850,000 Shares
FaceValue 10
Company Profile
The company is engaged primarily in business of manufacturing pharmaceutical products. The company has also stared trading in grey fabrics.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-4.92%
1 Month
+13.62%
3 Month
+19.20%
6 Month
+66.88%
1 Year
+86.25%
2 Year
+108.60%
5 Year
+16.41%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 0.14 0.42 0.20 0.21 0.06 1.02 -127.09 -49.89 31.35
Return on Capital Employed (%) 4.75 3.83 3.16 2.46 2.55 0.93 -49.36 -23.82 16.18
Return on Assets (%) 0.05 0.13 0.06 0.04 0.01 0.12 -25.58 -19.42 13.66

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 7 7 7 7 7 7 7 3 2 3
Non Curr. Liab. 5 5 6 5 4 4 0 0 0 0
Curr. Liab. 3 5 6 7 9 12 15 4 3 2
Minority Int.
Equity & Liab. 15 17 19 18 21 23 22 8 6 5
Non Curr. Assets 9 10 12 12 13 13 12 5 4 4
Curr. Assets 5 5 6 5 5 7 6 3 2 0
Misc. Exp. not W/O 1 2 1 2 3 4 4
Total Assets 15 17 19 18 21 23 22 8 6 5

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 13 15 17 17 8 6 7 6 1 0
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 13 15 17 17 8 6 7 6 1 0
Total Expenditure -12 -14 -16 -16 -7 -5 -10 -7 -1 0
PBIDT 1 1 1 1 1 1 -3 0 0 0
Interest -1 0 0 0 0 0 0 0 0
Depreciation 0 -1 0 -1 -1 -1 0 -1 0 0
Taxation 0 0 0 0 0
Exceptional Items 0 1 1
PAT 0 0 0 0 0 -4 -1 1 1
Adjusted EPS 0 0 0 0 0 -6 -2 1 2

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 2 1 0 1 2 1 -1 -11 0 0
Cash Fr. Inv. -1 -1 -2 0 -3 -3 0 11 0
Cash Fr. Finan. -1 0 2 -1 1 4 0 0 0 0
Net Change 0 0 0 0 0 2 -2 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 2 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 31.46 31.46 31.46 31.46 31.46 30.45 30.17 30.17 30.17
Public 68.54 68.54 68.54 68.54 68.54 69.55 69.83 69.83 69.83
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 26 Sep 2022
Closure of Trading Window
Pursuant to BSEs Circular No. LIST/COMP/01/2019-20 dated 2nd April 2019 and as per Clause 4 of the Schedule B and other applicable regulations of SEBI (Prohibition of Insider Trading) Regulations 2015 this is to inform you that in terms of Companys Code of Conduct for Prevention of Insider Trading the Trading Window of the Company will remain closed with effect from 1st October 2022 till 48 hours after the declaration of Unaudited Financial Results for the quarter ended on 30th September 2022.
Mon, 19 Sep 2022
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
Adline Chem Lab Ltd has informed BSE regarding the details of Voting results of AGM under Regulation 44(3) of SEBI (LODR) Regulations 2015. Kindly Click here
Fri, 16 Sep 2022
Announcement Under Regulation 30 (LODR) - Proceedings Of 34Th Annual General Meeting Held Through VC/OAVM
We are enclosing herewith copy of the Minutes of the 34th Annual General Meeting of the Company held on 16th September 2022 through Video Conferencing (VC)/ Other Audio Visual Means (OAVM) for your records. This is in compliance with Regulation 30 of SEBI Listing Regulations

Technical Scans View Details >>

Fri, 23 Sep 2022
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 216,444.01 897.30 0.0%
Divi's Laboratories Ltd. 97,676.51 3,641.10 -0.8%
Cipla Ltd. 85,998.13 1,073.75 +0.8%
Dr. Reddy's Laboratories Ltd. 68,714.69 4,163.35 +0.8%
Apollo Hospitals Enterprise Ltd. 61,530.49 4,240.40 -0.9%
Torrent Pharmaceuticals Ltd. 51,200.03 1,513.70 0.0%
Max Healthcare Institute Ltd. 40,653.72 410.20 -1.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 55.65 897.30 0.0%
Divi's Laboratories Ltd. Consolidated 2022-06 31.45 3,641.10 -0.8%
Cipla Ltd. Consolidated 2022-06 34.59 1,073.75 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.00 4,163.35 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.65 4,240.40 -0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.10 1,513.70 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-06 64.55 410.20 -1.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.32 897.30 0.0%
Divi's Laboratories Ltd. Consolidated 2022-06 7.86 3,641.10 -0.8%
Cipla Ltd. Consolidated 2022-06 4.00 1,073.75 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.40 4,163.35 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.35 4,240.40 -0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.03 1,513.70 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.33 410.20 -1.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 897.30 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,641.10 -0.8%
Cipla Ltd. Consolidated 2022-03 0.04 1,073.75 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,163.35 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,240.40 -0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,513.70 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 410.20 -1.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 897.30 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,641.10 -0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,073.75 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,163.35 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,240.40 -0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,513.70 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 410.20 -1.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 897.30 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,641.10 -0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,073.75 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,163.35 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,240.40 -0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,513.70 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 410.20 -1.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 897.30 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,641.10 -0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,073.75 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,163.35 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,240.40 -0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,513.70 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 410.20 -1.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 897.30 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,641.10 -0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,073.75 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,163.35 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,240.40 -0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,513.70 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 410.20 -1.7%

FAQ's On Adline Chem Lab Ltd.

What is Adline Chem Lab share price?

Can I buy Adline Chem Lab shares now?

What is the Market Cap of Adline Chem Lab?

What are the key metrics to analyse Adline Chem Lab?

What is the 52 Week High and Low of Adline Chem Lab?